Sterling Investment Advisors (Pennsylvania)’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-120	Closed	-$1K	–	580
2022 Q2	$1K	Sell	120 -80	-40%	-$522	﹤0.01%	547
2022 Q1	$2K	Hold	200	–	–	﹤0.01%	552
2021 Q4	$3K	Hold	200	–	–	﹤0.01%	527
2021 Q3	$6K	Hold	200	–	–	﹤0.01%	474
2021 Q2	$7K	Hold	200	–	–	﹤0.01%	445
2021 Q1	$8K	Hold	200	–	–	﹤0.01%	427
2020 Q4	$12K	Buy	200 +80	+67%	+$8.67K	﹤0.01%	352
2020 Q3	$16K	Hold	120	–	–	0.01%	317
2020 Q2	$20K	Hold	120	–	–	0.01%	300
2020 Q1	$17K	Buy	120 +40	+50%	+$12.2K	0.01%	287
2019 Q4	$26K	Hold	80	–	–	0.01%	273
2019 Q3	$40K	Buy	80 +40	+100%	+$22.6K	0.02%	228
2019 Q2	$24K	Hold	40	–	–	0.01%	281
2019 Q1	$24K	Hold	40	–	–	0.01%	281
2018 Q4	$14K	Buy	+40	New	+$21.5K	0.01%	311

Other funds holding NBRV

VFA

Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s NBRV Position: Q3 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2022, closing a stake of 120 shares — an estimated $1K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in NBRV in Q4 2018 and held it in 15 quarters. The position peaked at $40K in Q3 2019. 13 funds tracked by Wall St. Rank hold NBRV as of Q3 2022.

Sterling Investment Advisors (Pennsylvania) reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2022 after selling out during the quarter.
Sterling Investment Advisors (Pennsylvania) sold 120 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2022, an estimated $1K.
Sterling Investment Advisors (Pennsylvania) first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q4 2018 and held it in 15 quarters.
Sterling Investment Advisors (Pennsylvania)'s Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $40K in Q3 2019.
13 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.